Eukaryotic cells coordinate growth with the availability of nutrients through the mechanistic target of rapamycin complex 1 (mTORC1), a master growth regulator. Leucine is of particular importance and activates mTORC1 via the Rag guanosine triphosphatases and their regulators GATOR1 and GATOR2. Sestrin2 interacts with GATOR2 and is a leucine sensor. Here we present the 2.7 angstrom crystal structure of Sestrin2 in complex with leucine. Leucine binds through a single pocket that coordinates its charged functional groups and confers specificity for the hydrophobic side chain. A loop encloses leucine and forms a lid-latch mechanism required for binding. A structure-guided mutation in Sestrin2 that decreases its affinity for leucine leads to a concomitant increase in the leucine concentration required for mTORC1 activation in cells. These results provide a structural mechanism of amino acid sensing by the mTORC1 pathway.
T he mechanistic target of rapamycin complex 1 (mTORC1) protein kinase is a major growth regulator that coordinates cell anabolism and catabolism with the availability of key nutrients such as amino acids (1) (2) (3) . Among the amino acids, leucine is of particular interest because of its ability to promote important physiological phenomena, including muscle growth and satiety (4) (5) (6) , in large part through the activation of mTORC1 (7, 8) . However, the biochemical mechanism of leucine sensing by the mTORC1 pathway has remained elusive.
Whereas growth factors, energy, and other inputs signal to mTORC1 primarily through the tuberous sclerosis complex-Rheb axis (9) (10) (11) , amino acids act by regulating the nucleotide state of the heterodimeric Rag guanosine triphosphatases (GTPases) and promoting the localization of mTORC1 to the lysosome, its site of activation (12) (13) (14) . Lysosomal amino acids including arginine are thought to signal to the Rags through a lysosomal membrane-associated complex consisting of the v-ATPase (vacuolar-type H + -dependent adenosine triphosphatase) (15) , the Ragulator complex (16) , and the putative arginine sensor SLC38A9 (17, 18) . Cytosolic leucine, however, signals to the Rags through a distinct pathway consisting of GATOR1, which is the GTPase-activating protein for RagA and RagB, and a pentameric protein complex of unknown function called GATOR2 (19, 20) .
Proteomic studies have identified the Sestrins as GATOR2-interacting proteins that inhibit mTORC1 only in the absence of amino acids (21, 22) . Subsequent in vitro studies demonstrated that the Sestrin2-GATOR2 interaction is sensitive specifically to leucine, which binds Sestrin2 with a dissociation constant of~20 mM. Human embryonic kidney (HEK)-293T cells expressing a Sestrin2 mutant that cannot bind leucine fail to activate mTORC1 in response to leucine, suggesting that Sestrin2 is the primary leucine sensor for the mTORC1 pathway in these cells (20) . However, Sestrin2 shares no sequence similarity with known amino acid-binding domains, raising the question of how this protein can detect leucine and signal its presence to mTORC1.
Here we present the structure of human Sestrin2 in complex with leucine, revealing in atomic detail the mechanism of leucine sensing by the mTORC1 pathway.
Structure of leucine-bound Sestrin2
To understand how Sestrin2 detects leucine, we expressed and purified full-length human Sestrin2 from Escherichia coli and verified binding to leucine in vitro by differential scanning fluorimetry ( fig. S1 ) (23) . Although we were unable to obtain crystals of Sestrin2 alone, incubation of the protein with leucine allowed the formation of crystals containing leucine-bound Sestrin2 that diffracted to 2.7 Å resolution. We solved the structure using single-wavelength anomalous dispersion with selenomethionine-derivatized protein and refined the model against the native data to final working and free residuals, R work and R free , of 19.6% and 22.3%, respectively (table S1). Sestrin2 crystallized in a cubic space group containing five copies per asymmetric unit.
Sestrin2 is a 55-kD, monomeric, all a-helical, globular protein that contains distinct N-terminal (NTD, residues 66 to 220) and C-terminal (CTD, residues 339 to 480) domains connected by a partially disordered, partially helical linker domain (residues 221 to 338) (Fig. 1A) . The N-terminal 65 residues of the protein appear disordered and were not observed in our structure. Electron density map analysis revealed the presence of a single leucine molecule bound to Sestrin2 in the CTD (Fig. 2A) .
The NTD and CTD of Sestrin2 appear to be structurally similar and superpose well, with a root mean square deviation (RMSD) of~3.0 Å over 55 aligned Ca positions, despite a low sequence identity of 10.9% (Fig. 1B) . Furthermore, the two domains make extensive contacts with each other, primarily through the two core hydrophobic helices N9 and C7, burying 1872 Å 2 of surface area (Fig. 1A) .
A small region in the N terminus of Sestrin2 has weak sequence similarity to the bacterial alkylhydroperoxidase AhpD (24) . Analysis of our structure with the National Center for Biotechnology Information's Vector Alignment Search Tool [VAST (25) ] showed that Sestrin2 shares a common fold with the carboxymucolactone decarboxylase (CMD) protein family, consisting of bacterial g-CMD as well as AhpD (Pfam database identification number: PF02627). Despite low sequence similarity, Sestrin2 strongly resembles an AhpD homodimer, with each half of Sestrin2 matching a single AhpD molecule ( Fig. 1C and fig. S2A ). The NTD and CTD both superpose well with Ralstonia eutropha AhpD, with RMSDs of~2.0 Å over 129 and 101 Ca positions, respectively. Thus, Sestrin2 structurally resembles an intramolecular homodimer of two CMD-like domains, despite extensive divergence in the primary sequence.
To test the importance of the intramolecular contacts between the two domains of Sestrin2, we expressed the FLAG-tagged N-and C-terminal halves either alone or together as separate polypeptides and performed coimmunoprecipitation analysis. Although neither domain alone bound GATOR2, the separated halves, when expressed together, bound strongly both to each other and to GATOR2 (Fig. 1D) . Similarly, although neither half of Sestrin2 alone bound to leucine, the coexpressed halves did bind leucine (Fig. 1E) . Therefore, the NTD and CTD of Sestrin2 interact stably with each other and are both required for the interactions with GATOR2, as well as with leucine.
In addition to its role as a leucine sensor and GATOR2 inhibitor, Sestrin2 has been reported to have peroxiredoxin reductase activity, based in large part on its weak sequence similarity to bacterial AhpD, which does have this activity (24) . However, other groups have failed to reproduce this finding (26) . The active site of AhpD contains two cysteines, both of which are required for its catalytic activity (26, 27) . Superposing our Sestrin2 structure with AhpD confirms previous reports (24, 26) that only one of these active site residues is present in the N-terminal half of Sestrin2 (Cys 125 ), whereas both are absent from the C-terminal half ( fig. S2B ). This suggests that Sestrin2 either does not reduce peroxiredoxins or does so through an entirely different mechanism than does AhpD.
Sestrin2 is also reported to inhibit the mTORC1 pathway by directly acting as a guanine nucleotide dissociation inhibitor (GDI) fig. S2C ), and Sestrin2 shows no structural similarity to known GDI proteins.
Recognition of leucine by Sestrin2
Sestrin2 binds leucine through a single pocket formed at the intersection of helices C2, C3, and C7 in the CTD. Charged residues Glu 451 and Arg 390 form two sides of the pocket and anchor leucine in place through salt bridges with the free amine and carboxyl groups, respectively (Fig. 2, A (Fig. 2, A and B). The depth and overall hydrophobicity of this pocket floor make it well suited to accommodate leucine (Fig. 2B) .
To test the importance of these protein-ligand interactions, we generated a series of Sestrin2 leucine-pocket mutants. Disrupting the electrostatic coordination of the free amine by switching a single oxygen atom in Glu 451 to nitrogen [Glu 451 →Gln 451 (E451Q)] resulted in a complete loss of leucine binding, as did eliminating the interaction between Arg 390 and the free carboxyl (R390A; Fig. 2C ). In addition, although leucine readily triggered dissociation of the wild-type Sestrin2-GATOR2 complex, both the E451Q and R390A mutants remained constitutively bound to GATOR2, even in the presence of leucine (Fig.  2D ). The hydrophobic integrity of the pocket floor is also critical: The insertion of a single charged residue (W444E) was sufficient to abolish any detectable interaction with leucine ( Fig. 2 , C and D). Consistent with an essential role for these residues in leucine sensing, a multiple sequence alignment of Sestrin homologs showed that both Glu 451 and Arg 390 are strictly conserved in Sestrin proteins across phylogenetically diverse organisms, as is the hydrophobic nature of the pocket floor (Fig. 2E) .
These results provide a molecular explanation for how the Sestrin2-mTORC1 pathway specifically detects leucine and not other amino acids. Although Glu 451 and Arg 390 probably interact with any amino acid containing free amine and carboxyl groups, the hydrophobic base of the pocket excludes all charged and polar amino acids. Furthermore, large hydrophobic residues such as phenylalanine will clash with Trp 444 in the pocket floor, whereas small aliphatic amino acids such as alanine or valine will fail to make favorable van der Waals contacts. Thus, only leucine and the structurally similar amino acids isoleucine and methionine interact appreciably. This is consistent with the finding that only leucine and, to a much A lid-latch mechanism is required for leucine binding by Sestrin2
In addition to contacting the charged sides and hydrophobic base of the pocket, a "lid" formed by a loop connecting helices C2 and C3 encloses the top of the leucine, so that it is completely buried within the structure (Fig. 2A) . Three highly conserved threonine residues (Thr 374 , Thr 377 , and Thr 386 ) are positioned directly above the leucine and help coordinate the free amine and carboxyl groups, locking the ligand in place (Figs. 2E and  3A) . The side chain hydroxyl groups of Thr 374 and Thr 386 make hydrogen bond contacts with the carboxyl group of leucine, whereas the free amine donates a hydrogen bond to the backbone carbonyl of Thr 377 ( Figs. 2A and 3A) . To analyze the importance of these lid interactions for leucine detection by Sestrin2, we generated mutants that we predicted would eliminate the critical contacts between the lid and leucine. Mutation of either Thr 374 or Thr 386 (T374A or T386A) abolished the interaction with leucine and resulted in a constitutive interaction with GATOR2 (Fig. 3, C and D) , demonstrating a crucial role for the lid in leucine binding.
Although our in vitro binding data demonstrated a requirement for both the N-and C-terminal halves of Sestrin2 (Fig. 1D ), the structural model shows that the bound leucine only makes direct contacts with residues in the CTD (Fig. 2A) . Further structural analysis, however, revealed that the lid residue Tyr 375 forms a tight hydrogen bond with the N-terminal residue His 86 , located in a loop between helices N2 and N3 adjacent to the leucinebinding pocket (Fig. 3B) . This interaction appears to form a "latch," which locks the lid in place over the bound leucine. This interdomain contact appears to be critical for the Sestrin2-leucine interaction, given that specifically eliminating this hydrogen-bonded latch with either a Y375F or H86A mutation abolished leucine binding (Fig.  3, C and D) . Both Tyr 375 and His 86 are also highly conserved in Sestrin proteins across organisms (Fig. 2E and fig. S4 ). The requirement for His 86 to maintain the latch interaction probably explains why the NTD of the protein is also essential for the interaction with leucine.
Altering the leucine sensitivity of the mTORC1 pathway in cells
One prediction for a bona fide cellular leucine sensor is that its affinity for leucine should in part determine the sensitivity of the mTORC1 pathway to leucine. We tested this hypothesis directly by generating a mutant of Sestrin2 with a lower affinity for leucine. We predicted that deepening the hydrophobic base of the pocket by mutating Trp 444 to Leu (W444L) would reduce the van der Waals contacts with the bound leucine side chain, thereby weakening but not eliminating the interaction (Fig. 4A) . Consistent with this, the Sestrin2 W444L mutant bound one-sixth to one-eighth the amount of leucine that bound to wild-type Sestrin2 (Fig.  4B) . Furthermore, the addition of~10 to 15 times more leucine was required to fully dissociate the W444L mutant from GATOR2, as compared with wild-type Sestrin2 (Fig. 4C) .
To test the effect of this mutation on mTORC1 signaling in cells, we used a HEK-293T cell line in which Sestrin1, -2, and -3 were knocked out by the CRISPR-Cas9 system (Sestrin TKO cells). The mTORC1 signaling in these cells is fully resistant to leucine deprivation, and reintroduction of wildtype Sestrin2 restores normal signaling, with halfmaximal mTORC1 activity occurring on addition of~20 to 50 mM leucine (Fig. 4D) (20) . Expression of Sestrin2 W444L in the Sestrin TKO lines, however, shifted the dose response of mTORC1 to leucine, so that addition of~250 to 500 mM was required to achieve half-maximal activation of the pathway (Fig. 4D) . Thus, the affinity of Sestrin2 for leucine is a major determinant of the sensitivity of the mTORC1 pathway to leucine in human cells.
Although the overall hydrophobicity of the pocket floor is well conserved, the specific residues present at the W444 and F447 positions vary across organisms, and some organisms, including Drosophila, carry the corresponding W444L mutation (Fig. 2E) . These differences may alter the shape and depth of the leucine-binding pocket, leading to different affinities or specificities for leucine in different organisms. This may represent an evolutionary adaptation to enable efficient sensing of leucine concentrations that are physiologically relevant in these organisms.
Characterizing the GATOR2 binding site on Sestrin2
To better understand how leucine binding triggers dissociation of Sestrin2 from GATOR2, we sought to structurally characterize the GATOR2 binding interface of Sestrin2. Mutagenesis studies identified residue S190 in the NTD as required for GATOR2 binding (20) ; however, this site is distal to the leucine-binding pocket. Mapping electrostatic potential onto the solvent-exposed surface of Sestrin2 revealed a region in close proximity to the leucine-binding site that contains the highly conserved charged residues Asp 406 and Asp
407
( Fig. 5A and fig. S5 , A and B). Mutating these residues to alanine (DD406-7AA) completely eliminated GATOR2 binding without affecting leucine binding (Fig. 5B and fig. S5C ), suggesting that this region is required for the Sestrin2-GATOR2 interaction. Therefore, Sestrin2 may make multiple contacts with GATOR2 through both the NTD and CTD (Figs. 5C and 1B) , consistent with both halves of Sestrin2 being required for GATOR2 binding (Fig. 1D ).
Conclusions
Our results provide a structural model of leucine sensing by the Sestrin2-mTORC1 pathway and shed light on the mechanism through which mTORC1 couples cell growth to leucine availability. The structure shows that Sestrin2 contains an evolutionarily unique leucine-binding pocket consisting of a hydrophobic floor that determines specificity for the side chain of leucine, with adjacent glutamate and arginine residues that coordinate the free amine and carboxyl groups, respectively. An additional lid-latch mechanism helps lock the ligand in place and is required for binding.
Our structure also reveals a highly conserved GATOR2 binding site in close proximity to the leucine-binding pocket, suggesting possible mechanisms for how leucine binding can cause dissociation of Sestrin2 from GATOR2. The key residues for the GATOR2 interaction, Asp 406 and Asp
407
, are located on a loop separated from the lid of the pocket by the 15-residue helix C3 ( change to the GATOR2 binding site via movement of helix C3 (Fig. 5D) . Alternatively, a segment of the partially disordered linker domain, which contacts the leucine-binding pocket via Leu261 in helix L1 ( fig. S3A ), is also in close proximity to the GATOR2 binding site in our structure (Fig. 5C ). Therefore, changes in the leucinebinding state of Sestrin2 could potentially alter the position of the linker domain, thereby affecting the availability of the GATOR2 binding site. Despite these insights, several important questions remain. Fully understanding how leucine binding causes dissociation of Sestrin2 from GATOR2 will probably require ascertaining the structure of either apo-Sestrin2 or the Sestrin2-GATOR2 complex. Furthermore, understanding the exact mechanism by which Sestrin2 inhibits the mTORC1 pathway awaits the elucidation of the molecular function of GATOR2.
Finally, as a critical regulator of cell growth, mTORC1 is misregulated in various human diseases, including cancer and diabetes, as well as in aging (1, 29) . By revealing the mechanism through which a natural small molecule regulates this pathway, our results may enable the identification of compounds to pharmacologically target the nutrient-sensing pathway upstream of mTORC1 in vivo. The extremely high melting point of many ceramics adds challenges to additive manufacturing as compared with metals and polymers. Because ceramics cannot be cast or machined easily, three-dimensional (3D) printing enables a big leap in geometrical flexibility.We report preceramic monomers that are cured with ultraviolet light in a stereolithography 3D printer or through a patterned mask, forming 3D polymer structures that can have complex shape and cellular architecture.These polymer structures can be pyrolyzed to a ceramic with uniform shrinkage and virtually no porosity. Silicon oxycarbide microlattice and honeycomb cellular materials fabricated with this approach exhibit higher strength than ceramic foams of similar density. Additive manufacturing of such materials is of interest for propulsion components, thermal protection systems, porous burners, microelectromechanical systems, and electronic device packaging.
I
n comparison with metals and polymers, ceramics are difficult to process, particularly into complex shapes. Because they cannot be cast or machined easily, ceramics are typically consolidated from powders by sintering or deposited in thin films. Flaws, such as porosity and inhomogeneity introduced during processing, govern the strength because they initiate cracks, and-in contrast to metals-brittle ceramics have little ability to resist fracture. This processing challenge has limited our ability to take advantage of ceramics' impressive properties, including hightemperature capability, environmental resistance, and high strength. Recent advances in additive manufacturing have led to a multitude of different techniques, but all additive manufacturing techniques developed for ceramic materials are powderbased layer-by-layer processes that are restricted to a small number of compositions (1, 2) . Only a few of the commercially available three-dimensional (3D) printing systems offer printing of ceramics, either by selective curing of a photosensitive resin that contains ceramic particles, selective deposition of a liquid binder agent onto ceramic particles (binder jetting), or selective fusion of a powder bed with a laser (3, 4) . All these techniques are limited by slow fabrication rates, and in many cases, a time-consuming binder removal process. By starting with powders, consolidation to a dense part is an almost insurmountable challenge, and residual porosity is typically unavoidable. Furthermore, many additive processes introduce large thermal gradients that tend to cause cracks in ceramics. Pores, cracks, and inhomogeneities are responsible for the low strength and poor reliability of additively manufactured ceramic parts.
Polymer-derived ceramics were discovered in the 1960s (5 
